Similarly, complementary studies employing fluorescence-tracked IL-15/anti-PD-1 combinations have revealed dynamic spatiotemporal interactions between tumor microenvironments and secondary lymphoid organs, revealing mechanistic synergies in immunotherapy (30). Here, IL15 is linked to neoplasm.